Intensity Therapeutics (INTS) announces that the company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market stating that the Staff has determined that the company has regained compliance with Nasdaq’s minimum Stockholders’ Equity Requirement. “We are pleased with regaining compliance with the minimum Stockholders’ Equity Requirement based on our positive fundraising efforts through the end of July 2025,” said Lewis Bender, President and CEO of Intensity. “Based on the cash raised through July 2025, we now project to have sufficient cash to fund our current operating plan into the second half of 2026.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics Raises $6.6 Million in July Offering
- Intensity Therapeutics raises $6.6M from ATM stock sales in July
- Intensity Therapeutics initiated with a Buy at ThinkEquity
- Intensity Therapeutics Holds Annual Stockholders’ Meeting
- Intensity Therapeutics: INT230-6 achieved 100% complete response rate in MPNST